retatrutide trials in boston Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Triple hormone receptor agonist retatrutide

How long does it take for GLP-1 medications to improve liver health

Previous studies have estimated that the economic burden of sarcopenia in the United States accounts for approximately 1.5% of total national health expenditures [7], with annual per capita healthcare costs rising by $2,315.7 in individuals with sarcopenia [8]

Clinical Trials Only: Available only to enrolled research participants

These habits do more to tip the scale towards fat loss, not muscle loss

If you take high doses of carnitine for increasing fat loss, energy, or muscle mass and notice a fishy odor, you may be one of the unfortunate people that experience the smelly side effect of carnitine supplements

doi: 10.1016/j.molmet.2019.09.010 12 BaggioLLDruckerDJ